Skip to main content

‘Adheron’

Merryman wins $6M to address heart disease with arthritis drug, fund other research

Feb. 1, 2017—A Vanderbilt biomedical engineering professor has garnered $6 million total in grants to determine how to treat heart valve disease, pulmonary hypertension and heart failure using drugs originally developed for rheumatoid arthritis and applying the lessons learned from failed weight loss drugs. The larger grant to Associate Professor of Biomedical Engineering David Merryman – the result...

Read more